9-(3-hydroxy-2-phosphonomethoxypropyl)-2,6-diaminopurine has been researched along with HIV in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balzarini, J; De Clercq, E; Holy, A; Jindrich, J; Naesens, L; Schols, D; Snoeck, R | 1 |
1 other study(ies) available for 9-(3-hydroxy-2-phosphonomethoxypropyl)-2,6-diaminopurine and HIV
Article | Year |
---|---|
Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine.
Topics: Adenine; Animals; Antimetabolites; Antineoplastic Agents; Antiviral Agents; Cytopathogenic Effect, Viral; DNA Viruses; Herpesviridae; HIV; Mice; Moloney murine sarcoma virus; Organophosphorus Compounds; Retroviridae; Sarcoma, Experimental; Stereoisomerism | 1993 |